IL17A and Alzheimer disease: Our study aimed to evaluate inflammatory cytokines CSF IL-6 and IL-17A in patients with vascular cognitive impairment of the subcortical small-vessel disease subtype in order to discriminate vascular from neurodegenerative causes of dementia, particularly AD.